Retrieve available abstracts of 35 articles: HTML format
Single Articles
October 2025
KATZ LS, Scott DK, Stewart AF SIRT2 puts the brakes on human beta cell proliferation: therapeutic opportunities
and next challenges.
J Clin Invest. 2025;135:e197142. PubMedAbstract available
September 2025
SASSI G, Lemaitre P, Fernandez Calvo L, Lodi F, et al Neutrophil-enriched gene signature correlates with teplizumab therapy resistance
in different stages of type 1 diabetes.
J Clin Invest. 2025 Sep 30:e176403. doi: 10.1172/JCI176403. PubMedAbstract available
DOS SANTOS T, Dai XQ, Jones RC, Spigelman AF, et al Altered immune and metabolic molecular pathways drive islet cell dysfunction in
human type 1 diabetes.
J Clin Invest. 2025 Sep 30:e195267. doi: 10.1172/JCI195267. PubMedAbstract available
VIRGILIO E, Tielens S, Bonfield G, Nian FS, et al Recessive TMEM167A variants cause neonatal diabetes, microcephaly and epilepsy
syndrome.
J Clin Invest. 2025 Sep 9:e195756. doi: 10.1172/JCI195756. PubMedAbstract available
MEAKIN PJ, Coull BM, Tuharska Z, McCaffery C, et al Expression of Concern for Elevated circulating amyloid concentrations in obesity
and diabetes promote vascular dysfunction.
J Clin Invest. 2025;135:e199125. PubMed
August 2025
TAVARES-FERREIRA D, Shen BQ, Mwirigi JM, Shiers S, et al Cell and molecular profiles in peripheral nerves shift toward inflammatory
phenotypes in diabetic peripheral neuropathy.
J Clin Invest. 2025 Aug 19:e184075. doi: 10.1172/JCI184075. PubMedAbstract available
KONG YX, Rehan R, Moreno CL, Madsen S, et al SEC61B regulates calcium flux and platelet hyperreactivity in diabetes.
J Clin Invest. 2025;135:e184597. PubMedAbstract available
MIRZADEH Z, Morton GJ, Hirsch IB, Schwartz MW, et al An unexpected role for the brain in the pathogenesis of diabetic ketoacidosis.
J Clin Invest. 2025;135:e196357. PubMed
CHOE J, Belmonte P, Crotts S, Nguyen T, et al ST8Sia6 overexpression protects pancreatic beta cells from spontaneous autoimmune
diabetes in nonobese diabetic mice.
J Clin Invest. 2025;135:e181207. PubMedAbstract available
July 2025
SINGH AK, Bernabucci M, Dvorak NM, Haghighijoo Z, et al Sensory neuron-expressed FGF13 controls nociceptive signaling in diabetic
neuropathy models.
J Clin Invest. 2025;135:e183749. PubMedAbstract available
LI X, Hu J, Huang Y, Zhang H, et al Trapalpha deficiency impairs the early events of insulin biosynthesis and glucose
homeostasis.
J Clin Invest. 2025;135:e179845. PubMedAbstract available
NEWSOME PN, Loomba R Therapeutic horizons in metabolic dysfunction-associated steatohepatitis.
J Clin Invest. 2025;135:e186425. PubMedAbstract available
June 2025
TOMLINSON JW Should GLP-1 receptor agonist therapy be used to treat obesity in Bardet-Biedl
syndrome?
J Clin Invest. 2025;135:e191822. PubMedAbstract available
May 2025
COSTANTINO S, Mohammed SA, Paneni F Endothelial dysfunction in patients with type 2 diabetes: the truth is in the
blood.
J Clin Invest. 2025;135:e193128. PubMedAbstract available
SARKAR M, Kushner T Metabolic dysfunction-associated steatotic liver disease and pregnancy.
J Clin Invest. 2025;135:e186426. PubMedAbstract available
GOU Y, Glat M, Damian V, Bryan CL, et al AgRP neuron hyperactivity drives hyperglycemia in a mouse model of type 2
diabetes.
J Clin Invest. 2025;135:e189842. PubMedAbstract available
PETRIE GN, Mayo LM GLP-1 receptor agonists for the treatment of alcohol use disorder.
J Clin Invest. 2025;135:e192414. PubMedAbstract available
April 2025
GATTU AK, Tanzer M, Yaron-Barir TM, Johnson JL, et al Cell-intrinsic insulin signaling defects in human iPS cell-derived hepatocytes in
type 2 diabetes.
J Clin Invest. 2025;135:e183513. PubMedAbstract available
March 2025
COLLADO A, Humoud R, Kontidou E, Eldh M, et al Erythrocyte-derived extracellular vesicles induce endothelial dysfunction through
arginase-1 and oxidative stress in type 2 diabetes.
J Clin Invest. 2025 Mar 20:e180900. doi: 10.1172/JCI180900. PubMedAbstract available
December 2024
CATTIN-ROY AN, Laffey KG, Le LB, Schrum AG, et al Reduced thymic IL-4 impairs negative T cell selection in nonobese diabetic mice.
J Clin Invest. 2024;134:e163417. PubMedAbstract available
October 2024
CHOI YJ, Richard G, Zhang G, Hodgin JB, et al Attenuated kidney oxidative metabolism in young adults with type 1 diabetes.
J Clin Invest. 2024 Oct 22:e183984. doi: 10.1172/JCI183984. PubMedAbstract available
OTENG AB, Liu L, Cui Y, Gavrilova O, et al Activation of Gs signaling in mouse enteroendocrine K-cells greatly improves
obesity- and diabetes-related metabolic deficits.
J Clin Invest. 2024 Oct 22:e182325. doi: 10.1172/JCI182325. PubMedAbstract available
September 2024
DOLTON G, Bulek A, Wall A, Thomas H, et al HLA A*24:02-restricted T cell receptors cross-recognize bacterial and
preproinsulin peptides in type 1 diabetes.
J Clin Invest. 2024;134:e164535. PubMedAbstract available
CAPERA J, Dustin ML Microbial mimics supersize the pathogenic self-response.
J Clin Invest. 2024;134:e184046. PubMedAbstract available
August 2024
STERLING JK, Rajesh A, Droho S, Gong J, et al Retinal perivascular macrophages regulate immune cell infiltration during
neuroinflammation in mouse models of ocular disease.
J Clin Invest. 2024;134:e180904. PubMedAbstract available
DING J, Nguyen AT, Lohman K, Hensley MT, et al LXR signaling pathways link cholesterol metabolism with risk for prediabetes and
diabetes.
J Clin Invest. 2024;134:e185290. PubMed
LLEDO-DELGADO A, Preston-Hurlburt P, Currie S, Clark P, et al Teplizumab induces persistent changes in the antigen-speci fi c repertoire in
individuals at-risk for type 1 diabetes.
J Clin Invest. 2024 Aug 13:e177492. doi: 10.1172/JCI177492. PubMedAbstract available
July 2024
SCHRADER LA, Ronnekleiv-Kelly SM, Hogenesch JB, Bradfield CA, et al Circadian disruption, clock genes, and metabolic health.
J Clin Invest. 2024;134:e170998. PubMedAbstract available
June 2024
MURALIDHARAN C, Huang F, Enriquez JR, Wang JE, et al Inhibition of the eukaryotic initiation factor-2-alpha kinase PERK decreases risk of
autoimmune diabetes in mice.
J Clin Invest. 2024 Jun 18:e176136. doi: 10.1172/JCI176136. PubMedAbstract available
HAEMMERLE MW, Scota AV, Khosravifar M, Varney MJ, et al RNA-binding protein PCBP2 regulates pancreatic beta cell function and adaptation to
glucose.
J Clin Invest. 2024;134:e172436. PubMedAbstract available
May 2024
DING J, Nguyen AT, Lohman K, Hensley MT, et al LXR signaling pathways link cholesterol metabolism with risk for prediabetes and
diabetes.
J Clin Invest. 2024;134:e173278. PubMedAbstract available
SABADELL-BASALLOTE J, Astiarraga B, Castano C, Ejarque M, et al SUCNR1 regulates insulin secretion and glucose elevates the succinate response in
people with prediabetes.
J Clin Invest. 2024;134:e173214. PubMedAbstract available
April 2024
YANG J, Zhuang H, Li J, Nunez-Nescolarde AB, et al The secreted micropeptide C4orf48 enhances renal fibrosis via an RNA-binding
mechanism.
J Clin Invest. 2024;134:e178392. PubMedAbstract available
March 2024
DI GIUSEPPE G, Soldovieri L, Ciccarelli G, Ferraro PM, et al Reduced incretin effect precedes diabetes development following
duodenopancreatectomy in subjects without diabetes.
J Clin Invest. 2024 Mar 12:e175133. doi: 10.1172/JCI175133. PubMed
DEFRONZO RA SGLT2 inhibitors: cardiorenal metabolic drugs for the ages.
J Clin Invest. 2024;134:e177625. PubMed